Conjugated Estrogens vs Famotidine: side-by-side comparison
Conjugated Estrogens (Hormone replacement therapy (estrogen mixture)) and Famotidine (H2-receptor antagonist) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Conjugated Estrogens | Famotidine |
|---|---|---|
| Therapeutic class | Hormone replacement therapy (estrogen mixture) | H2-receptor antagonist |
| CAS | 12126-59-9 | 76824-35-6 |
| ATC | G03CA57 | A02BA03 |
| Molecular weight | 265-272 g/mol (mixture) | 337.45 g/mol |
| Brands with this active ingredient | 1 | 1 |
What they share
Conjugated Estrogens and Famotidine share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Conjugated Estrogens acts by a different mechanism than Famotidine, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Conjugated Estrogens: Conjugated estrogens act on estrogen receptors throughout the body, restoring estrogen signalling lost after menopause. Famotidine: Famotidine reversibly and competitively blocks histamine H2 receptors on gastric parietal cells, reducing both basal and stimulated gastric acid secretion.
Indications compared
Conjugated Estrogens: Conjugated estrogens are approved for moderate to severe vasomotor symptoms of menopause, vulvovaginal atrophy due to menopause, osteoporosis prevention in postmenopausal women at significant risk, and primary ovarian fa… Famotidine: Famotidine is approved in adults and children for short-term treatment of active duodenal and gastric ulcer, maintenance therapy of duodenal ulcer, gastro-oesophageal reflux disease, Zollinger-Ellison syndrome and other…
Safety profile
Conjugated Estrogens: Common adverse effects include nausea, breast tenderness, fluid retention, headache and breakthrough bleeding. Famotidine: Famotidine is generally well tolerated.
Frequently asked questions
Is Conjugated Estrogens better than Famotidine? ▾
Conjugated Estrogens and Famotidine are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Conjugated Estrogens and Famotidine be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Conjugated Estrogens
Products with Famotidine
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.